ID: ALA3980112

Max Phase: Preclinical

Molecular Formula: C26H32N6O6S

Molecular Weight: 556.65

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  N=C(N)NCCCCC(=O)Nc1ccc(C[C@H](NC(=O)[C@@H]2C=CCN2S(=O)(=O)c2ccccc2)C(=O)O)cc1

Standard InChI:  InChI=1S/C26H32N6O6S/c27-26(28)29-15-5-4-10-23(33)30-19-13-11-18(12-14-19)17-21(25(35)36)31-24(34)22-9-6-16-32(22)39(37,38)20-7-2-1-3-8-20/h1-3,6-9,11-14,21-22H,4-5,10,15-17H2,(H,30,33)(H,31,34)(H,35,36)(H4,27,28,29)/t21-,22-/m0/s1

Standard InChI Key:  DKMKGQACSCOXGQ-VXKWHMMOSA-N

Associated Targets(Human)

Integrin alpha-V/beta-1 222 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 556.65Molecular Weight (Monoisotopic): 556.2104AlogP: 1.02#Rotatable Bonds: 13
Polar Surface Area: 194.78Molecular Species: ZWITTERIONHBA: 6HBD: 6
#RO5 Violations: 2HBA (Lipinski): 12HBD (Lipinski): 7#RO5 Violations (Lipinski): 3
CX Acidic pKa: 3.16CX Basic pKa: 12.00CX LogP: -0.50CX LogD: -0.50
Aromatic Rings: 2Heavy Atoms: 39QED Weighted: 0.09Np Likeness Score: -0.62

References

1. Reed NI, Tang YZ, McIntosh J, Wu Y, Molnar KS, Civitavecchia A, Sheppard D, DeGrado WF, Jo H..  (2016)  Exploring N-Arylsulfonyl-l-proline Scaffold as a Platform for Potent and Selective αvβ1 Integrin Inhibitors.,  (10): [PMID:27774126] [10.1021/acsmedchemlett.6b00196]

Source